GBT Reports Recent Business Progress and Third Quarter 2020 Financial Results

NEXT STORY
Calithera Biosciences Reports Third Quarter 2020 Financial Results and Recent Highlights
PREV STORY
Ziopharm Oncology Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BioMarin Receives Orphan Drug Designation From FDA for First AAV-Factor VIII Gene Therapy, BMN 270, for Patients With Hemophilia A

SAN RAFAEL, Calif., March 01, 2016 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced ...

author_avatar
NASDAQ Market News

Kura Oncology to Report Fourth Quarter and Full Year 2018 Financial Results

author_avatar
NASDAQ Market News

Prediction of Survival in Patients with Chronic Liver Disease: a Study Confirms the Clinical Benefit of ShearWave Elastography

author_avatar
NASDAQ Market News